Recently TrialSite showcased that Texas A&M University not only emerged as a top research center in America, joining the $1+ billion club but that one of its professors developed a possible treatment for COVID-19 that crushed Merck’s molnupiravir in head-to-head laboratory tests. Now TrialSite shares that the Texas A&M University Health Science Center (Texas A&M Health) secured a $5.5 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT). Actually allocated to four faculty members, these 4 are among the 72 awards allocated by CPRIT totaling over $142 million the public cancer research institute reported.
What follows is a summary of Texas A&M research now funded thanks to the CPRIT funding. Jon Mogford, chief operating officer and senior vice president for Texas A&M Health shared on the topic “It is an honor to see so many Texas A&M Health faculty recognized through these distinguished CPRIT grants and the support it provides to all the families and lives impacted by cancer.”
Recently Lindsey Hendrix with Texas A&M University Health Center wrote an accounting of the studies now made possible thanks to the funding via ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).